DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
Current Location:
> This Story

Log in or Register to rate this News Story
Forward Printable StoryPrint Comment



Oncology Homepage

Is low cost Proton-to-Carbon Heavy Ion radiotherapy coming soon? Best Particle Therapy plans to bring smaller footprint system to market in two to three years

Researchers develop AI approach for high-risk clinical tumor volumes Assisting low- and middle-income countries that lack contouring expertise

Dr. Benjamin Movsas American Radium Society Names president-elect

European medical center first to perform linac-based MR-guided RT using on-table adaptation Made possible with ViewRay's MRIdian Linac

Hospital in Italy performs radiosurgery with Brainlab's Elements Spine SRS software Automatically plans treatments for complex parts of the body

AI approach used to study Mars now assessing tumor response to therapies Could reduce sample sizes and accelerate process for approval of cancer therapies

Thermal imaging in development could provide real-time ablation views Taking guesswork and additional imaging out of the equation

PPI to purchase Elekta MR-linac systems for £25 million Will install at five cancer centers across the UK

Dr. Nancy P. Mendenhall Medical Director of UF Health Proton Therapy selected by University of Florida as 2018 Clinical Science Researcher of the Year

ViewRay showcases enhancements to MRIdian Linac system at ESTRO Will offer MR pulse sequencing capabilities

Governor Bill Haslam has vetoed a
bill that would require state employee
insurance to cover proton therapy

Tennessee governor vetoes state employee proton therapy coverage

by John R. Fischer , Staff Reporter
Tennessee Governor Bill Haslam (R.) has vetoed a bill that would make coverage for proton therapy mandatory under state employee insurance plans.

Haslam asserted that the bill, passed by both the Tennessee House and Senate, would burden patients with excessive charges from out-of-network providers and put them at risk. The bill was sponsored by physician and senator Mark Green (R.) and representative Bob Ramsey (R.).

Story Continues Below Advertisement

OR Tables, Treatment/GYN/Uro Chairs, Transport Stretchers, Hospital/ICU Bed

iMS combines the superior service of Oakworks Medical and advanced manufacturing technology of FAMED Medical Solutions. The goal of iMS, "Connecting Art and Medical Science" goes way beyond product with exceptional CareLink service. Contact us today!

“The provider advocating this bill rejected a medically appropriate plan for expanded coverage to instead pursue a political mandate,” Haslam said in a statement. “The state is committed to high-quality care that is medically appropriate and fiscally responsible for patients and taxpayers, but this mandate could put patients at risk and expose them to excessive charges from out-of-network providers.”

If passed, the bill would require the state group insurance program to cover physician prescribed hypofractionated proton therapy under the same aggregate amount as intensity-modulated radiation therapy.

Coverage would extend to patients in a clinical trial or registry and prescribed by a board certified radiation oncologist. Aggregate cost would be required to equal the average cost paid by the state for an entire course of IMRT treatment for the delivery of the same biologically effective dose.

Prior to the veto, the bill cleared way to become law in both the Tennessee Senate and House in votes of 29-1 and 82-13, respectively.

Green and Ramsey have called for a special meeting to consider overriding the veto, a move supported by executive director Scott Warwick of The National Association for Proton Therapy.

“His statement that the bill could 'put patients at risk and expose them to excessive charges from out-of-network providers' is incorrect and misguided,” Warwick told HCB News. “The bill's language, which improves access for cancer patients on the state health plan who would benefit from hypofractionated proton therapy, explicitly states that there will be no additional cost over standard IMRT to the patient, the state, or its insurers. We hope that the Tennessee legislature, who in an overwhelming majority voted in favor of this bill, will reconvene for a special session to override the veto in support of cancer patients across the state.”

Dr. Green, a survivor of colon cancer who did not have the option of proton therapy, says the bill would ensure that others have access to another, and in many cases, more effective alternative to conventional radiation that was not available to him.
  Pages: 1 - 2 >>

Oncology Homepage

You Must Be Logged In To Post A Comment

Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Gold Service Dealer Program
Receive RFP/PS
Healthcare Providers
See all
HCP Tools
A Job
Parts Hunter +EasyPay
Get Parts
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to, Inc. Copyright ©2001-2018, Inc.